vs
Side-by-side financial comparison of BIOLIFE SOLUTIONS INC (BLFS) and Recon Technology, Ltd (RCON). Click either name above to swap in a different company.
BIOLIFE SOLUTIONS INC is the larger business by last-quarter revenue ($18.8M vs $12.2M, roughly 1.5× Recon Technology, Ltd). BIOLIFE SOLUTIONS INC runs the higher net margin — 58.9% vs -6.8%, a 65.8% gap on every dollar of revenue. On growth, Recon Technology, Ltd posted the faster year-over-year revenue change (111.0% vs 24.3%).
Biolife Solutions Inc. develops, manufactures and distributes specialized biopreservation products and cold chain management solutions for the cell and gene therapy, biopharmaceutical and regenerative medicine industries. It offers cryopreservation media, automated thawing systems, and temperature monitoring tools, serving biotech firms, research institutions and clinical labs globally.
Recon Instruments Inc. was a Canadian technology company that produced smartglasses and wearable displays marketed by the company as "heads-up displays" for sports. Recon's products delivered live activity metrics, GPS maps, and notifications directly to the user's eye. Recon's first heads-up display offering was released commercially in October 2010, roughly a year and a half before Google introduced Google Glass.
BLFS vs RCON — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $18.8M | $12.2M |
| Net Profit | $11.1M | $-832.7K |
| Gross Margin | — | 33.5% |
| Operating Margin | 7.2% | -14.6% |
| Net Margin | 58.9% | -6.8% |
| Revenue YoY | 24.3% | 111.0% |
| Net Profit YoY | -11.1% | 70.5% |
| EPS (diluted) | $0.23 | $-0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.8M | $12.2M | ||
| Q3 25 | $28.1M | — | ||
| Q2 25 | $25.4M | — | ||
| Q1 25 | $23.9M | — | ||
| Q4 24 | $15.1M | $5.8M | ||
| Q3 24 | $21.4M | — | ||
| Q2 24 | $19.7M | — | ||
| Q1 24 | $18.4M | — |
| Q4 25 | $11.1M | $-832.7K | ||
| Q3 25 | $621.0K | — | ||
| Q2 25 | $-15.8M | — | ||
| Q1 25 | $-448.0K | — | ||
| Q4 24 | $12.5M | $-2.8M | ||
| Q3 24 | $-1.7M | — | ||
| Q2 24 | $-20.7M | — | ||
| Q1 24 | $-10.2M | — |
| Q4 25 | — | 33.5% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 31.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 7.2% | -14.6% | ||
| Q3 25 | -0.3% | — | ||
| Q2 25 | -65.5% | — | ||
| Q1 25 | -5.1% | — | ||
| Q4 24 | 3.6% | -63.9% | ||
| Q3 24 | -2.0% | — | ||
| Q2 24 | -6.6% | — | ||
| Q1 24 | -17.9% | — |
| Q4 25 | 58.9% | -6.8% | ||
| Q3 25 | 2.2% | — | ||
| Q2 25 | -62.3% | — | ||
| Q1 25 | -1.9% | — | ||
| Q4 24 | 82.5% | -48.9% | ||
| Q3 24 | -8.0% | — | ||
| Q2 24 | -105.1% | — | ||
| Q1 24 | -55.4% | — |
| Q4 25 | $0.23 | $-0.09 | ||
| Q3 25 | $0.01 | — | ||
| Q2 25 | $-0.33 | — | ||
| Q1 25 | $-0.01 | — | ||
| Q4 24 | $0.27 | $-0.31 | ||
| Q3 24 | $-0.04 | — | ||
| Q2 24 | $-0.45 | — | ||
| Q1 24 | $-0.22 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $33.0M | $10.7M |
| Total DebtLower is stronger | $5.0M | — |
| Stockholders' EquityBook value | $371.9M | $66.4M |
| Total Assets | $405.9M | $77.6M |
| Debt / EquityLower = less leverage | 0.01× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $33.0M | $10.7M | ||
| Q3 25 | $29.5M | — | ||
| Q2 25 | $31.9M | — | ||
| Q1 25 | $66.9M | — | ||
| Q4 24 | $91.5M | $19.9M | ||
| Q3 24 | $24.0M | — | ||
| Q2 24 | $22.0M | — | ||
| Q1 24 | $29.7M | — |
| Q4 25 | $5.0M | — | ||
| Q3 25 | $7.5M | — | ||
| Q2 25 | $10.1M | — | ||
| Q1 25 | $12.9M | — | ||
| Q4 24 | $15.9M | — | ||
| Q3 24 | $20.1M | — | ||
| Q2 24 | $21.1M | — | ||
| Q1 24 | $24.3M | — |
| Q4 25 | $371.9M | $66.4M | ||
| Q3 25 | $353.7M | — | ||
| Q2 25 | $347.2M | — | ||
| Q1 25 | $352.6M | — | ||
| Q4 24 | $348.9M | $66.9M | ||
| Q3 24 | $325.5M | — | ||
| Q2 24 | $321.4M | — | ||
| Q1 24 | $333.4M | — |
| Q4 25 | $405.9M | $77.6M | ||
| Q3 25 | $392.1M | — | ||
| Q2 25 | $387.2M | — | ||
| Q1 25 | $395.1M | — | ||
| Q4 24 | $399.5M | $74.2M | ||
| Q3 24 | $381.7M | — | ||
| Q2 24 | $375.0M | — | ||
| Q1 24 | $401.6M | — |
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.02× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.04× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.06× | — | ||
| Q2 24 | 0.07× | — | ||
| Q1 24 | 0.07× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.9M | $-1.9M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.9M | $-1.9M | ||
| Q3 25 | $6.1M | — | ||
| Q2 25 | $7.4M | — | ||
| Q1 25 | $1.7M | — | ||
| Q4 24 | $1.6M | $-1.7M | ||
| Q3 24 | $4.8M | — | ||
| Q2 24 | $6.5M | — | ||
| Q1 24 | $-4.5M | — |
| Q4 25 | 0.44× | — | ||
| Q3 25 | 9.83× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
